1.67
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immune Therapeutics Inc (PK) | IMUN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.67 | 07:50:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.67 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 1.02 - 5.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.67 | USD |
Period:
Draw Mode:
Immune Therapeutics Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 807.84k | 483.74k | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 39.99k | $ - | - | - | - |
Immune Therapeutics (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.70 | 1.70 | 1.65 | 1.69 | 611 | -0.03 | -1.76% |
| 1 Month | 1.70 | 2.20 | 1.55 | 1.72 | 385 | -0.03 | -1.76% |
| 3 Months | 1.75 | 2.85 | 1.0301 | 1.99 | 2,687 | -0.08 | -4.57% |
| 6 Months | 1.75 | 2.90 | 1.0301 | 1.82 | 2,137 | -0.08 | -4.57% |
| 1 Year | 4.745 | 5.35 | 1.02 | 2.49 | 1,860 | -3.08 | -64.81% |
| 3 Years | 0.0047 | 7.99 | 0.0038 | 0.020705 | 1,102,494 | 1.67 | 35,431.91% |
| 5 Years | 0.0489 | 7.99 | 0.0027 | 0.0204323 | 984,157 | 1.62 | 3,315.13% |
Immune Therapeutics (PK) Description
| Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. |